FIG 3.
(A) Binimetinib treatment group: univariate analysis of molecular alterations and response to therapy. (B) Physician’s choice chemotherapy group: univariate analysis of molecular alterations and response to therapy. OR, odds ratio.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.